Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Dextroamphetamine for cocaine-dependence treatment: A double-blind randomized clinical trial
John Grabowski
, Howard Rhoades
, Joy Schmitz
, Angela Stotts
, Lee Ann Daruzska
, Dan Creson
, F. Gerard Moeller
Administration (TMED)
Research output
:
Contribution to journal
›
Article
›
peer-review
232
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dextroamphetamine for cocaine-dependence treatment: A double-blind randomized clinical trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Placebo
100%
Cocaine Dependence
100%
Dextroamphetamine
100%
Double-blind Randomized Clinical Trial
100%
Randomized Placebo-controlled Trial
50%
Cocaine
50%
Treatment Regimen
50%
Psychostimulants
50%
Agonist Treatment
50%
Behavioral Therapy
50%
Urine Samples
50%
Illicit Drugs
50%
Urine Screening
50%
Active Groups
50%
Benzoylecgonine
50%
Dose-finding Design
50%
Dextroamphetamine Sulfate
50%
Sustained-release Capsules
50%
Design Subject
50%
Therapy Session
50%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
100%
Placebo
100%
Cocaine Dependence
100%
Dexamphetamine
100%
Sustained Release
33%
Psychostimulant
33%
Benzoylecgonine
33%